191 related articles for article (PubMed ID: 28387323)
1. CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.
Cheng DD; Lin HC; Li SJ; Yao M; Yang QC; Fan CY
Sci Rep; 2017 Apr; 7():46238. PubMed ID: 28387323
[TBL] [Abstract][Full Text] [Related]
2. Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.
Cheng DD; Zhang HZ; Yuan JQ; Li SJ; Yang QC; Fan CY
Oncotarget; 2017 Apr; 8(16):26380-26393. PubMed ID: 28460433
[TBL] [Abstract][Full Text] [Related]
3. CNOT1 cooperates with LMNA to aggravate osteosarcoma tumorigenesis through the Hedgehog signaling pathway.
Cheng DD; Li J; Li SJ; Yang QC; Fan CY
Mol Oncol; 2017 Apr; 11(4):388-404. PubMed ID: 28188704
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
5. Expression of MSH2 and MSH6 on a tissue microarray in patients with osteosarcoma.
Jentzsch T; Robl B; Husmann M; Bode-Lesniewska B; Fuchs B
Anticancer Res; 2014 Dec; 34(12):6961-72. PubMed ID: 25503122
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
[TBL] [Abstract][Full Text] [Related]
7. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
8. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
[TBL] [Abstract][Full Text] [Related]
9. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
Qu G; Ma Z; Tong W; Yang J
Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
[TBL] [Abstract][Full Text] [Related]
11. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
12. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
Sun W; Wang W; Lei J; Li H; Wu Y
Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential.
Sun R; Shen J; Gao Y; Zhou Y; Yu Z; Hornicek F; Kan Q; Duan Z
Oncotarget; 2016 Jun; 7(25):38333-38346. PubMed ID: 27223261
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis.
Wang F; Ke ZF; Sun SJ; Chen WF; Yang SC; Li SH; Mao XP; Wang LT
Cancer Biol Ther; 2011 Sep; 12(6):539-48. PubMed ID: 21750404
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor associates with survival and regulates tumour progression in osteosarcoma.
Tieken C; Verboom MC; Ruf W; Gelderblom H; Bovée JV; Reitsma PH; Cleton-Jansen AM; Versteeg HH
Thromb Haemost; 2016 May; 115(5):1025-33. PubMed ID: 26763081
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
[TBL] [Abstract][Full Text] [Related]
18. Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?
Yuksel UM; Turker I; Dilek G; Dogan L; Gulcelik MA; Oksuzoglu B
Oncol Res Treat; 2015; 38(9):431-4. PubMed ID: 26278417
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
Cong M; Li J; Jing R; Li Z
Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
Chen F; Mo J; Zhang L
Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]